EMERGING IOL TECHNOLOGY, SMILE WITH THE VISUMAX 800 & TRANS-EPITHELIAL CROSS-LINKING
Date: 11/10/2023 (AEDT)
Venue: 36 College Street, Darlinghurst, NSW, 2010
Provider: Vision Clinic Sydney
Contact: Amanda El-Akkad, [E] clinical@visionclinicsydney.com.au, [P] 9222 9188
Learning Objectives
- Participants should be able to describe and understand the different types of intraocular lenses (IOLs) available in the market for cataract surgery and refractive lens exchange.
- Participants should be able to stay up to date with emerging intraocular lens technologies and their potential benefits for patients.
- Participants should be able to understand the role of corneal topography, pupillography and lens technology for identifying an appropriate IOL for cataract surgery or refractive lens exchange.
- Participants should be able to evaluate the outcomes of SMILE surgery using the VisuMax 800 laser and compare them to other laser vision correction procedures, such as LASIK.
- Participants should be able to define the benefits and features of SMILE laser surgery and the role of the VisuMax 800 laser in this procedure.
- Participants understand the differences and benefits of transepithelial collagen cross-linking compared with Dresden protocol of cross-linking.
- Participants should be able to revise the pathogenesis of glaucoma.
- Participants should be able to identify and understand the visual field defects experienced by glaucoma sufferers.
- Participants should be able to appreciate and understand the value of optical coherence tomography (OCT) in the diagnosis of glaucoma.
Max CPD hours awarded: 3
Session Information
Name |
---|
Emerging IOL technologies |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.75 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.25 |
Name |
---|
SMILE and the Visumax 800 |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.5 |
Name |
---|
Transepithelial collagen cross-linking in keratoconus management |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.5 |
Name |
---|
Glaucoma - Pathogenesis, Visual Field Defects & The Role of OCT in Diagnosis |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.75 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.75 |